In a meta-analysis of whether Tα1 was used in combination with UTI, the combination of UTI and Tα1 for severe sepsis reduced mortality at 28 and 90 days, whereas Tα1 alone reduced mortality only at 28 days [80]. Here, TAAR1 is linked to bacterial urinary tract infection.